about
Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study.Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors.A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on SurvivalInhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancerLDB1 overexpression is a negative prognostic factor in colorectal cancer.A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer.Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis.TLR activation and ionizing radiation induce strong immune responses against multiple tumor entities.Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.Postoperative course and prognostic value of circulating angiogenic cytokines after pancreatic cancer resection.Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling.Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer.Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses[Antibiotic treatment vs. appendectomy for non-perforated appendicitis in adults]Nuclear Translocation of RELB is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in MiceHuman gastric cancer modelling using organoidsCompartmental differences of circulating tumor cells in colorectal cancerCirculating Tumor CellsMouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway AlterationsThe overall potential of CD47 in cancer immunotherapy: with a focus on gastrointestinal tumorsThe prognostic role of circulating tumor cells in colorectal cancerPrognostic value of DLGAP5 in colorectal cancerSerum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer
P50
Q35475513-9F69FB62-2B00-4C8E-8C83-749A2240F516Q35741529-F49B25DE-5756-42FB-92D1-FB726746AA62Q36172919-C9EA0A80-F10A-4597-BEFD-199C2AD71582Q36340248-E932A800-E8AB-4992-8415-2C4D43B9C218Q37708941-143EA729-C9D9-45B7-B87C-FAFB2CBE0D9DQ40120148-79B10E95-8F31-43F7-96E0-1179D3A16F35Q41434342-AEC406DF-81A8-46EF-8C81-7CDD4CD3B8B0Q41578773-6936F244-E76F-4A8E-B5B2-FB6F3B2A4265Q41755749-19D3F790-1ED4-45D7-9803-6D6F1625C1D7Q42700802-EF3FFC4C-1897-47B5-9E0C-5408A77B295FQ42704783-68CDF07B-D0D1-4C63-BEB1-3AD79427844FQ51819604-19A49F87-0ED0-427F-893A-9A972822DBB5Q57325915-2664B527-F0B8-471D-9E4B-60A5B728FB8BQ58113253-7213164F-A891-4164-AA9A-5558DD8C0618Q59350812-FC5B7D17-7936-4109-A3C0-5021412816FFQ63406942-22581950-D625-4FA6-AB6C-6E41DF1ECAA2Q83199388-CD2D6A3E-74EE-4873-9E0D-E0455773A7C1Q89159623-6982B7AB-3934-4382-9E6B-931F33115077Q90484299-F0380673-99F2-4C85-B65E-632C9A225019Q91110164-102A9222-EF11-4A8D-B39E-A59EDAF02243Q91506460-38DE9EAD-7E4F-428A-AF4A-C56188B2654BQ91728474-7C90FCFD-33E3-45B7-84B1-AFE860AD28E8Q92266428-C3F54739-9C4C-45A5-829E-7DEDFEC76AE0
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sebastian Schölch
@ast
Sebastian Schölch
@en
Sebastian Schölch
@es
Sebastian Schölch
@nl
Sebastian Schölch
@sl
type
label
Sebastian Schölch
@ast
Sebastian Schölch
@en
Sebastian Schölch
@es
Sebastian Schölch
@nl
Sebastian Schölch
@sl
prefLabel
Sebastian Schölch
@ast
Sebastian Schölch
@en
Sebastian Schölch
@es
Sebastian Schölch
@nl
Sebastian Schölch
@sl
P106
P21
P31
P496
0000-0003-0012-3177